Page 92 | Certara

Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Publication

QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation

Typical Quantitative Systems Pharmacology (QSP) workflows involve discussion of biology, supported by graphical diagrams, followed…

CertaraMay 25, 2023

Conference

American College of Toxicology 2025 Annual Meeting

– – Booth

CertaraMay 24, 2023

Conference

ISPOR Europe 2025

–

CertaraMay 24, 2023

Conference

ACoP 2025

CertaraMay 24, 2023

Press Coverage

Dose Optimization: Getting it Right for Vulnerable Populations

By: Justin Hay & Frank Engler Pandemics amplify existing strengths and vulnerabilities—not only highlighting who…

CertaraMay 22, 2023

Blog

Japan’s Approach to Pediatric Drug Development: What You Need to Know

Access to safe and effective medications is critical for pediatric patients, yet 60-70% of medicines…

CertaraMay 22, 2023

Announcement

Certara’s Synchrogenix Writer now enhanced with AI Layar

Next generation automation for Medical Writers to streamline the creation of regulatory documents Certara is…

CertaraMay 11, 2023

Case Study

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…

CertaraMay 9, 2023

Press Coverage

The Impact of the Inflation Reduction Act on Biosimilar Uptake

In an interview with HCPLive, Maximilian Vargas, PhD, MBA, vice president of the United States…

CertaraMay 8, 2023

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation

American College of Toxicology 2025 Annual Meeting

ISPOR Europe 2025

ACoP 2025

Dose Optimization: Getting it Right for Vulnerable Populations

Japan’s Approach to Pediatric Drug Development: What You Need to Know

Certara’s Synchrogenix Writer now enhanced with AI Layar

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

The Impact of the Inflation Reduction Act on Biosimilar Uptake

Newsletter sign up

Quick links

Solutions

Contact